NASDAQ:ICUI - ICU Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$221.46 -7.12 (-3.11 %)
(As of 12/16/2018 04:00 PM ET)
Previous Close$221.46
Today's Range$220.67 - $228.57
52-Week Range$211.25 - $321.70
Volume353,351 shs
Average Volume259,888 shs
Market Capitalization$4.54 billion
P/E Ratio40.12
Dividend YieldN/A
Beta0.62
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV solutions, such as normal salines, ringers, etc., which are used to replenish fluids and electrolytes; irrigation solutions to hydrate the wound, remove deep debris, assist with visual examination, to prevent infection, and improve healing; and nutritional solutions that feed vitamins, minerals, and other natural therapeutic substances directly into the blood stream. In addition, the company offers infusion pumps under the Plum 360, LifeCare PCA, SapphirePlus, and Sapphire names; Cogent 2-in-1 and LiDCO LX1 hemodynamic monitoring systems; CardioFlo hemodynamic monitoring sensors; TriOx PICC invasive venous oximetry sensors; SafeSet closed blood sampling and conservation systems; Transpac consumable blood pressure transducers; and Q2 Plus continuous cardiac output/oximetry systems. The company sells its products primarily to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ICUI
Previous Symbol
CUSIP44930G10
Phone949-366-2183

Debt

Debt-to-Equity RatioN/A
Current Ratio4.51
Quick Ratio3.07

Price-To-Earnings

Trailing P/E Ratio40.12
Forward P/E Ratio28.54
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.29 billion
Price / Sales3.51
Cash Flow$9.0355 per share
Price / Cash Flow24.51
Book Value$59.52 per share
Price / Book3.72

Profitability

EPS (Most Recent Fiscal Year)$5.52
Net Income$68.64 million
Net Margins6.00%
Return on Equity15.20%
Return on Assets12.40%

Miscellaneous

Employees6,802
Outstanding Shares20,490,000
Market Cap$4.54 billion
OptionableOptionable

ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

How were ICU Medical's earnings last quarter?

ICU Medical, Incorporated (NASDAQ:ICUI) announced its quarterly earnings data on Thursday, November, 8th. The medical instruments supplier reported $1.85 earnings per share for the quarter, beating analysts' consensus estimates of $1.51 by $0.34. The medical instruments supplier earned $327.20 million during the quarter, compared to analyst estimates of $334.97 million. ICU Medical had a net margin of 6.00% and a return on equity of 15.20%. The firm's revenue for the quarter was down 4.7% on a year-over-year basis. During the same quarter last year, the business posted $1.12 EPS. View ICU Medical's Earnings History.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for ICU Medical.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical updated its FY18 earnings guidance on Thursday, November, 8th. The company provided EPS guidance of $8.45-8.85 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.60. ICU Medical also updated its FY 2018 guidance to $8.45-8.85 EPS.

Has ICU Medical been receiving favorable news coverage?

News headlines about ICUI stock have trended positive this week, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. ICU Medical earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the company's share price in the next several days.

Who are some of ICU Medical's key competitors?

Who are ICU Medical's key executives?

ICU Medical's management team includes the folowing people:
  • Mr. Vivek Jain, Chairman & CEO (Age 46)
  • Mr. Scott E. Lamb, CFO & Treasurer (Age 55)
  • Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 60)
  • Ms. Alison D. Burcar, Corp. VP of Product Strategy for IV Consumables (Age 45)
  • Mr. Steven C. Riggs, Exec. Officer of Special Project Opertions (Age 59)

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc (7.24%), Vanguard Group Inc. (7.24%), BlackRock Inc. (6.99%), Janus Henderson Group PLC (6.70%), Wells Fargo & Company MN (2.48%) and JPMorgan Chase & Co. (2.40%). Company insiders that own ICU Medical stock include Alison D Burcar, Daniel Woolson, George A Lopez, Joseph R Saucedo, Pfizer Inc, Richard Md Sherman, Robert S Swinney, Scott E Lamb, Steven Riggs, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Institutional Ownership Trends for ICU Medical.

Which institutional investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Dimensional Fund Advisors LP, Federated Investors Inc. PA, Morgan Stanley, Teachers Advisors LLC, Castleark Management LLC, Royce & Associates LP and Eagle Asset Management Inc.. Company insiders that have sold ICU Medical company stock in the last year include Alison D Burcar, Daniel Woolson, George A Lopez, Joseph R Saucedo, Pfizer Inc, Robert S Swinney, Scott E Lamb, Thomas D Mccall and Virginia Ruth Sanzone. View Insider Buying and Selling for ICU Medical.

Which institutional investors are buying ICU Medical stock?

ICUI stock was purchased by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Vanguard Group Inc, Vanguard Group Inc., Marshall Wace LLP, TIAA CREF Investment Management LLC, Martingale Asset Management L P, BlackRock Inc. and FMR LLC. View Insider Buying and Selling for ICU Medical.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $221.46.

How big of a company is ICU Medical?

ICU Medical has a market capitalization of $4.54 billion and generates $1.29 billion in revenue each year. The medical instruments supplier earns $68.64 million in net income (profit) each year or $5.52 on an earnings per share basis. ICU Medical employs 6,802 workers across the globe.

What is ICU Medical's official website?

The official website for ICU Medical is http://www.asgn.com.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]


MarketBeat Community Rating for ICU Medical (NASDAQ ICUI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  269 (Vote Outperform)
Underperform Votes:  266 (Vote Underperform)
Total Votes:  535
MarketBeat's community ratings are surveys of what our community members think about ICU Medical and other stocks. Vote "Outperform" if you believe ICUI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICUI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel